TEA
Official title: Tolerance and effect of antipsychotics in children and adolescents with psychosis - An investigator-initiated, phase IV, randomised double-blind multi-centre trial of the benefits and harms of aripiprazole versus quetiapine in children and adolescents with psychosisTrial start year: 2010
Trial website
No website available
Design paper
2014
Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial
Download full paperResult paper
2017
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial
Download full paper